LASA SUPERGENERICS
Back to Balance Sheet
|
LASA SUPERGENERICS Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹49 Cr | ₹43 Cr | ₹45 Cr | ₹41 Cr | ₹76 Cr |
What is the latest Total Current Liabilities ratio of LASA SUPERGENERICS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2024 | ₹49 Cr |
| Mar2023 | ₹43 Cr |
| Mar2022 | ₹45 Cr |
| Mar2021 | ₹41 Cr |
| Mar2020 | ₹76 Cr |
How is Total Current Liabilities of LASA SUPERGENERICS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2024 | ₹49 Cr | 14.38 | |
| Mar2023 | ₹43 Cr | -4.52 | |
| Mar2022 | ₹45 Cr | 10.40 | |
| Mar2021 | ₹41 Cr | -46.61 | |
| Mar2020 | ₹76 Cr | - | |
Compare Total Current Liabilities of peers of LASA SUPERGENERICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LASA SUPERGENERICS | ₹45.1 Cr | -4.1% | -20.6% | -64.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,559.0 Cr | 7.1% | -1.5% | -6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,827.0 Cr | 2.8% | -2.8% | 6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,942.0 Cr | 3.1% | 4.2% | 18.8% | Stock Analytics | |
| CIPLA | ₹106,825.0 Cr | 0.2% | -12.5% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,077.0 Cr | 2.2% | -1.6% | 0% | Stock Analytics | |
LASA SUPERGENERICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LASA SUPERGENERICS | -4.1% |
-20.6% |
-64.2% |
| SENSEX | 1.7% |
-1.7% |
10.3% |
You may also like the below Video Courses